Inhibition of system Xc− transporter attenuates autoimmune inflammatory demyelination

KS Evonuk, BJ Baker, RE Doyle… - The Journal of …, 2015 - journals.aai.org
T cell infiltration into the CNS is a significant underlying pathogenesis in autoimmune
inflammatory demyelinating diseases. Several lines of evidence suggest that glutamate …

Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes

N Berghmans, H Heremans, S Li, E Martens… - Journal of …, 2012 - Springer
Background Neutrophil influx is an important sign of hyperacute neuroinflammation,
whereas the entry of activated lymphocytes into the brain parenchyma is a hallmark of …

Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination

J Nessler, K Bénardais, V Gudi, A Hoffmann… - PLoS one, 2013 - journals.plos.org
For the treatment of patients with multiple sclerosis there are no regenerative approaches to
enhance remyelination. Mesenchymal stem cells (MSC) have been proposed to exert such …

N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis

N Tokuhara, K Namiki, M Uesugi, C Miyamoto… - Journal of Biological …, 2010 - ASBMB
One of the family of voltage-gated calcium channels (VGCC), the N-type Ca 2+ channel, is
located predominantly in neurons and is associated with a variety of neuronal responses …

Adenosine: Adenosine Receptor (AR) Axis in Blood Brain Barrier (BBB) Permeability Regulation

MS Bynoe - The Journal of Immunology, 2019 - journals.aai.org
Multiple sclerosis (MS) is a is a chronic, debilitating, neuroinflammatory disease that affects
the central nervous system (CNS). MS affects about 2.5 million patients world-wide. MS …

B-lymphocyte depletion for the treatment of multiple sclerosis: now things really get interesting

T Matsushita, TF Tedder - Expert review of neurotherapeutics, 2009 - Taylor & Francis
Conventional wisdom is that B lymphocytes are a major driving force behind autoantibody-
dependent autoimmune diseases, such as systemic lupus erythematosus, and the …

Deletion of Beta‐2‐Microglobulin Ameliorates Spinal Cord Lesion Load and Promotes Recovery of Brainstem NAA Levels in a Murine Model of Multiple Sclerosis

A Denic, I Pirko, B Wootla, A Bieber, S Macura… - Brain …, 2012 - Wiley Online Library
We used genetic deletion of β2‐microglobulin to study the influence of CD8+ T cells on
spinal cord demyelination, remyelination, axonal loss and brainstem N‐acetyl aspartate …

[HTML][HTML] Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis

AL Greenfield, R Dandekar, A Ramesh, EL Eggers… - JCI insight, 2019 - ncbi.nlm.nih.gov
B cells are key contributors to chronic autoimmune pathology in multiple sclerosis (MS).
Clonally related B cells exist in the cerebrospinal fluid (CSF), meninges, and CNS …

[HTML][HTML] Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice …

HA Alomar, A Nadeem, MA Ansari, SM Attia… - Brain Research …, 2023 - Elsevier
Multiple sclerosis (MS) is a severe autoimmune disease leading to demyelination, followed
by consequent axonal degeneration, causing sensory, motor, cognitive, and visual …

B cell treatments for multiple sclerosis

D McLauchlan, NP Robertson - Journal of neurology, 2017 - Springer
The established picture of immunological dysfunction in Multiple Sclerosis (MS) posits a
central role for T cells. As a consequence, the development of disease-modifying treatments …